A pioneering blood test that can detect more than 50 cancers before symptoms appear could save tens of thousands of lives a year, promising new research suggests.
Results of an NHS-backed trial show the Galleri test – dubbed ‘the Holy Grail’ for cancer – helps flag four times as many cancers when added to current screening programmes.
In practice this could prevent one in five late-stage diagnoses – a major contributor to the 170,000 cancer deaths a year in the UK.
Doctors involved in the trial say the potential impact on survival is enormous, with up to 30,000 lives saved every year.
The test,
To provide well-rounded coverage and a breadth of insight across various events, we rely on contributions from several staff writers, each bringing their own area of expertise to our publication.
